Category of Chemicals

PI3K inhibitor

Phosphoinositide 3-kinases (PI3K) play a pivotal role in intracellular signaling, regulating essential cellular processes like cell growth, proliferation, and survival. Inhibitors targeting PI3K are a critical class of drugs in cancer therapy, where dysregulated PI3K signaling is often observed. By blocking PI3K activity, these inhibitors impede aberrant cell growth and promote programmed cell death, making them promising candidates for various cancer treatments.

Products of PI3K inhibitor
CAS No.	Product Name	Molecular Formula
1007207-67-1	[5-[7-Methylsulfonyl-2-(morpholin-4-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-yl]amine	C₁₅H₁₉N₇O₃S
1032568-63-0	2-Amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide	C₂₃H₂₈N₈O₄
1032754-93-0	GNE 390	C₂₃H₃₀N₈O₃S
1086062-66-9	GSK 2126458	C₂₅H₁₇F₂N₅O₃S
110-06-5	tert-Butyl disulfide	C₈H₁₈S₂
1159824-67-5	CZC 24832	C₁₅H₁₇FN₆O₂S
1166227-08-2	A 66	C₁₇H₂₃N₅O₂S₂
1173204-81-3	PKI 402	C₂₉H₃₄N₁₀O₃
1173900-33-8	AZD 6482	C₂₂H₂₄N₄O₄
1197160-78-3	N-[4-[[4-(Dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]urea	C₃₂H₄₁N₉O₄
1201438-56-3	Duvelisib	C₂₂H₁₇ClN₆O
1218777-13-9	(5E)-5-[[5-(4-Fluorophenyl)-2-furanyl]methylene]-2,4-thiazolidinedione	C₁₄H₈FNO₃S
1245537-68-1	NVP-BGT226	C₂₈H₂₅F₃N₆O₂.C₄H₄O₄
1246560-33-7	5-[8-Methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-2-pyrimidinamine	C₁₇H₂₂N₈O
1276110-06-5	6-[5-[(Phenylsulfonyl)amino]-3-pyridinyl]imidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester	C₂₁H₁₈N₄O₄S
1349796-36-6	N-[4-[[[3-[(3,5-Dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methylbenzamide	C₃₁H₂₉N₅O₆S
1372540-25-4	2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid	C₂₂H₂₂F₃N₃O₃
1394076-92-6	5-[6-(3-Methoxy-3-oxetanyl)-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-2-yl]-2-pyrimidinamine	C₁₉H₂₂N₆O₃S
154447-36-6	LY 294002	C₁₉H₁₇NO₃
371242-69-2	2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone	C₂₂H₁₉N₇O
371935-74-9	PI 103	C₁₉H₁₆N₄O₃
371942-69-7	YM 201636	C₂₅H₂₁N₇O₃
372196-77-5	PIK-75	C₁₆H₁₄BrN₅O₄S.HCl
475110-96-4	ZSTK 474	C₁₉H₂₁F₂N₇O₂
593960-11-3	PIK 93	C₁₄H₁₆ClN₃O₄S₂
648449-76-7	AS 604850	C₁₁H₅F₂NO₄S
648450-29-7	AS-605240	C₁₂H₇N₃O₂S
677297-51-7	3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol	C₁₈H₁₄N₆O₂
677338-12-4	PIK 90	C₁₈H₁₇N₅O₃
870281-82-6	5-Fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]-4(3H)-quinazolinone	C₂₂H₁₈FN₇O
900185-01-5	PIK-293	C₂₂H₁₉N₇O
900185-02-6	2-[[4-Amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone	C₂₈H₂₃N₇O₂
900515-16-4	AS 252424	C₁₄H₈FNO₄S
915019-65-7	NVP-BEZ 235	C₃₀H₂₃N₅O
925705-73-3	TG 100713	C₁₂H₁₀N₆O
944396-07-0	NVP-BKM-120	C₁₈H₂₁F₃N₆O₂
955977-50-1	6-[[4-(Cyclopropylmethyl)-1-piperazinyl]methyl]-2-(5-fluoro-1H-indol-4-yl)-4-(4-morpholinyl)-thieno[3,2-d]pyrimidine	C₂₇H₃₁FN₆OS
956958-53-5	XL 147	C₂₁H₁₆N₆O₂S₂
957054-30-7	GDC-0941	C₂₃H₂₇N₇O₃S₂
958852-01-2	GSK 1059615	C₁₈H₁₁N₃O₂S